172 related articles for article (PubMed ID: 12580565)
21. [Current progress in the diagnosis and treatment of renal cell carcinoma].
Tsukamoto T; Takahashi A; Kitamura H
Nihon Jinzo Gakkai Shi; 2002 Dec; 44(8):779-85. PubMed ID: 12607966
[No Abstract] [Full Text] [Related]
22. Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes.
Woodward ER; Clifford SC; Astuti D; Affara NA; Maher ER
J Med Genet; 2000 May; 37(5):348-53. PubMed ID: 10807693
[TBL] [Abstract][Full Text] [Related]
23. Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions.
Gallou C; Chauveau D; Richard S; Joly D; Giraud S; Olschwang S; Martin N; Saquet C; Chrétien Y; Méjean A; Correas JM; Benoît G; Colombeau P; Grünfeld JP; Junien C; Béroud C
Hum Mutat; 2004 Sep; 24(3):215-24. PubMed ID: 15300849
[TBL] [Abstract][Full Text] [Related]
24. Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney.
Yoshida M; Yao M; Ishikawa I; Kishida T; Nagashima Y; Kondo K; Nakaigawa N; Hosaka M
Genes Chromosomes Cancer; 2002 Dec; 35(4):359-64. PubMed ID: 12378530
[TBL] [Abstract][Full Text] [Related]
25. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
Zbar B
Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
[TBL] [Abstract][Full Text] [Related]
26. [Molecular genetic mechanism of the kidney cancer].
Nakaigawa N; Yao M; Kishida T; Kubota Y
Nihon Rinsho; 2001 Jan; 59(1):104-9. PubMed ID: 11197838
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
28. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation.
Lovell M; Lott ST; Wong P; El-Naggar A; Tucker S; Killary AM
Cancer Res; 1999 May; 59(9):2182-9. PubMed ID: 10232606
[TBL] [Abstract][Full Text] [Related]
29. Mutational analysis of endothelial cells derived from von Hippel-Lindau-related renal cancer.
Los M; Kerckhaert OA; Zewald R; van Amstel HK; Voest EE
J Natl Cancer Inst; 2000 Oct; 92(20):1688-9. PubMed ID: 11036115
[No Abstract] [Full Text] [Related]
30. The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma.
Sufan RI; Jewett MA; Ohh M
Am J Physiol Renal Physiol; 2004 Jul; 287(1):F1-6. PubMed ID: 15180922
[TBL] [Abstract][Full Text] [Related]
31. Molecular detection of von Hippel-Lindau gene mutations in urine and lymph node samples in patients with renal cell carcinoma: potential biomarkers for early diagnosis and postoperative metastatic status.
Ashida S; Furihata M; Tanimura M; Sugita O; Yamashita M; Miura T; Moriyama M; Shuin T
J Urol; 2003 Jun; 169(6):2089-93. PubMed ID: 12771725
[TBL] [Abstract][Full Text] [Related]
32. The von Hippel-Lindau tumor suppressor gene and kidney cancer.
Kaelin WG
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6290S-5S. PubMed ID: 15448019
[TBL] [Abstract][Full Text] [Related]
33. Parathyroid hormone-related protein is an essential growth factor for human clear cell renal carcinoma and a target for the von Hippel-Lindau tumor suppressor gene.
Massfelder T; Lang H; Schordan E; Lindner V; Rothhut S; Welsch S; Simon-Assmann P; Barthelmebs M; Jacqmin D; Helwig JJ
Cancer Res; 2004 Jan; 64(1):180-8. PubMed ID: 14729622
[TBL] [Abstract][Full Text] [Related]
34. Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma.
Gnarra JR; Duan DR; Weng Y; Humphrey JS; Chen DY; Lee S; Pause A; Dudley CF; Latif F; Kuzmin I; Schmidt L; Duh FM; Stackhouse T; Chen F; Kishida T; Wei MH; Lerman MI; Zbar B; Klausner RD; Linehan WM
Biochim Biophys Acta; 1996 Mar; 1242(3):201-10. PubMed ID: 8603073
[No Abstract] [Full Text] [Related]
35. Genetic alterations and histopathologic findings in familial renal cell carcinoma.
Hansel DE
Histol Histopathol; 2006 Apr; 21(4):437-44. PubMed ID: 16437389
[TBL] [Abstract][Full Text] [Related]
36. [Development of human renal cell carcinoma (RCC)--the responsible genes for the development of hereditary and sporadic human RCCs].
Shuin T; Kamata M; Ashida S
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1719-25. PubMed ID: 12402420
[TBL] [Abstract][Full Text] [Related]
37. Molecular epidemiology of VHL gene mutations in renal cell carcinoma patients: relation to dietary and other factors.
Hemminki K; Jiang Y; Ma X; Yang K; Egevad L; Lindblad P
Carcinogenesis; 2002 May; 23(5):809-15. PubMed ID: 12016154
[TBL] [Abstract][Full Text] [Related]
38. The von Hippel-Lindau tumor suppressor gene. A rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis.
Decker HJ; Weidt EJ; Brieger J
Cancer Genet Cytogenet; 1997 Jan; 93(1):74-83. PubMed ID: 9062583
[TBL] [Abstract][Full Text] [Related]
39. Mutations in the von Hippel-Lindau (VHL) gene refine differential diagnostic criteria in renal cell carcinoma.
Barnabas N; Amin MB; Pindolia K; Nanavati R; Amin MB; Worsham MJ
J Surg Oncol; 2002 May; 80(1):52-60. PubMed ID: 11967908
[TBL] [Abstract][Full Text] [Related]
40. The von Hippel-Lindau tumor suppressor gene protects cells from UV-mediated apoptosis.
Schoenfeld AR; Parris T; Eisenberger A; Davidowitz EJ; De Leon M; Talasazan F; Devarajan P; Burk RD
Oncogene; 2000 Nov; 19(51):5851-7. PubMed ID: 11127815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]